Article

Bovhyaluronidase azoximer for long-term pulmonary sequelae of COVID-19: a randomized, double-blind, placebo-controlled trial

2024-09-19

Abstract excerpt

<h4>Background</h4> Hyaluronan is an emerging target for COVID-19 and lung fibrosis. In an open-label study the hyaluronidase bovhyaluronidase azoximer (BA) was associated with improved pulmonary function and exercise tolerance in patients with pulmonary sequelae of COVID-19. In this randomized, double-blind, placebo-controlled trial we evaluated the effect of BA on patients up to 12 months after COVID-19, charact...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e82df14b-1c04-5225-ae42-3dde6dadc8a3
DOI: 10.1101/2024.09.19.24313792

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Bovhyaluronidase azoximer for long-term pulmonary sequelae of COVID-19: a randomized, double-blind, placebo-controlled trialDOI 10.1101/2024.09.19.24313792Read

Hyaluronan in COVID-19 morbidity, a bedside-to-bench approach to understand mechanisms and long-term consequences of hyaluronanSemantic proximity Read

A phase 2 study of the inhaled pan-JAK inhibitor TD-0903 in severe COVID-19: Part 1Semantic proximity Read

Randomised Controlled Trial of Intravenous Nafamostat Mesylate in COVID pneumonitis: Phase 1b/2a Experimental Study to Investigate Safety, Pharmacokinetics and PharmacodynamicsSemantic proximity Read

Inhaled Aviptadil for the treatment of COVID-19 in patients at high risk for ARDS: Study protocol for a randomized, placebo controlled multicentre trial.Semantic proximity Read

Human Mesenchymal Stem Cells Treatment for Severe COVID-19: 1-Year Follow-Up Results of a Randomized, Double-Blind, Placebo-Controlled TrialSemantic proximity Read

Home-use Photobiomodulation Device Treatment Outcomes for COVID-19Semantic proximity Read

HYDROXYCHLOROQUINE FOR THE TREATMENT OF SEVERE RESPIRATORY INFECTION BY COVID-19: A RANDOMIZED CONTROLLED TRIALSemantic proximity Read

Abordaje hemodinámico y ventilatorio en pacientes con COVID-19.Semantic proximity Read

Adhatoda Vasica: a potential ayurvedic intervention against COVID-19 associated impaired immune response and hypoxia-inflammation phenotypeSemantic proximity Read

Inhaled Fluticasone for Outpatient Treatment of Covid-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical TrialSemantic proximity Read

Usage of Compromised Lung Volume in Monitoring Steroid Therapy on Severe COVID-19Semantic proximity Read

Incidence of Corticosteroid and Hyaluronic Acid Injections and Risk of Hospitalization: A Population-Based Cohort Study (2010–2023)Semantic proximity Read